Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced cardiomyopathy in rats
AMA Azeez, GA Lazareva, AA Stepchenko - 2019 - dspace.bsu.edu.ru
Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced
cardiomyopathy in rats Page 1 957 EurAsian Journal of BioSciences Eurasia J Biosci 13 …
cardiomyopathy in rats Page 1 957 EurAsian Journal of BioSciences Eurasia J Biosci 13 …
Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced cardiomyopathy in rats
PD Kolesnichenko, IA Popova… - EurAsian Journal of …, 2019 - search.proquest.com
Introduction: Doxorubicin is the drug of choice in the treatment of many malignant
neoplasms, but its use is limited due to the risk of developing severe cardiomyopathy. This …
neoplasms, but its use is limited due to the risk of developing severe cardiomyopathy. This …
Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced cardiomyopathy in rats.
PD Kolesnichenko, IA Popova… - EurAsian Journal of …, 2019 - search.ebscohost.com
Introduction: Doxorubicin is the drug of choice in the treatment of many malignant
neoplasms, but its use is limited due to the risk of developing severe cardiomyopathy. This …
neoplasms, but its use is limited due to the risk of developing severe cardiomyopathy. This …
[PDF][PDF] Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced cardiomyopathy in rats
PD Kolesnichenko, IA Popova, DV Sheblykin… - EurAsian Journal of …, 2019 - core.ac.uk
Introduction: Doxorubicin is the drug of choice in the treatment of many malignant
neoplasms, but its use is limited due to the risk of developing severe cardiomyopathy. This …
neoplasms, but its use is limited due to the risk of developing severe cardiomyopathy. This …
Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced cardiomyopathy in rats
PD Kolesnichenko, IA Popova, DV Sheblykin… - EurAsian Journal of …, 2019 - elibrary.ru
Introduction: Doxorubicin is the drug of choice in the treatment of many malignant
neoplasms, but its use is limited due to the risk of developing severe cardiomyopathy. This …
neoplasms, but its use is limited due to the risk of developing severe cardiomyopathy. This …
[引用][C] Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced cardiomyopathy in rats
PD Kolesnichenko, IA Popova, DV Sheblykin… - 2019 - openrepository.ru
Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced
cardiomyopathy in rats - «Национальный агрегатор открытых репозиториев российских …
cardiomyopathy in rats - «Национальный агрегатор открытых репозиториев российских …